At $223.15, Arm Holdings (NASDAQ:ARM | ARM Price Prediction) screens as attractive to accumulators, with research desks pointing to the $210 to $215 range on any pullback as a favored entry zone. The stock has rebounded sharply from a steep first-quarter drawdown, and the post-earnings story has fundamentally changed what Arm is selling to Wall Street.
Arm designs the CPU architecture that sits inside nearly every smartphone on Earth, and it now licenses the IP and ships its own silicon into the heart of agentic AI data centers. That second business is the reason shares have surged 104.14% year to date and 33.84% in the last month alone. The launch of the Arm AGI CPU, Arm’s first production silicon for the data center, has flipped the narrative from royalty grinder to AI infrastructure principal.
Why The Pullback Zone Matters
The bull case starts with the AGI CPU demand curve. Customer commitments jumped from $1 billion to over $2 billion across FY2027 and FY2028 in just six weeks, with Meta locked in as lead co-development partner. Hyperscaler CPU share already sits at roughly 50%, with Google replacing x86 in next-gen TPUs using Axion, NVIDIA’s Vera CPU launching on Arm, and Microsoft expanding Cobalt across Azure.
The numbers underneath are accelerating. Q4 FY2026 revenue rose 20.06% to $1.49 billion, beating estimates, with non-GAAP EPS of $0.60 topping the $0.5793 consensus. Data center royalty more than doubled year over year, and ACV climbed 22% to $1.66 billion. CEO Rene Haas framed it directly: “As AI becomes more agentic, demand for Arm AGI CPU, Arm’s first data center chip, has exceeded expectations.”
The Bear Pushback
Valuation is the obvious problem. Arm trades at a trailing P/E of 250 and a forward P/E of 98, with a beta of 3.406. Non-GAAP operating margin compressed from 52.8% to 49.1% as R&D spending jumped 43% to $1.91 billion. RPO fell 7% year over year, and pending Qualcomm-Nuvia litigation, SoftBank’s controlling stake, and China export exposure all remain live risks.
Why Patience Could Still Pay
The hold argument rests on entry timing. Shares already gapped 7.32% in the past week and sit 4% below the 52-week high of $239.50. Q1 FY2027 guidance of $1.26 billion in revenue and $0.40 EPS implies sequential deceleration, and a market-wide AI rerating could send Arm back through $210 quickly given its volatility.
The Numbers Behind The Call
Arm currently trades at $223.15 against a consensus analyst target of $230.92, implying modest upside. Coverage breaks down across 39 analysts: 7 Strong Buy, 20 Buy, 10 Hold, 1 Sell, and 1 Strong Sell, with bullish sentiment at 69%. The cluster of targets is constructive, even with the usual caveats around analyst forecasts.
Year to date, ARM is up 104.14% versus a roughly flat S&P 500 over the same window, with SPY at $733.73. Over one year, shares are up 68.99%.
The Verdict On Arm At This Price
At $223.15, the bull case for Arm Holdings remains intact. Here is why.
The structural story has two reinforcing legs. Neoverse IP royalties are doubling year over year and management expects them to double again in FY2027. The AGI CPU adds a second vector tracking toward $15 billion in revenue by FY2031 inside a data center CPU TAM management pegs at over $100 billion by 2030.
The $210 to $215 zone is the accumulation sweet spot because it sits below the analyst target, above the 50-day moving average of $169.83, and aligns with last week’s breakout base. That level sits below the analyst target, above the 50-day moving average, and aligns with last week’s breakout base, making it the zone most cited by accumulators. The thesis breaks if AGI CPU shipments slip from the Q4 FY2027 first-revenue window or hyperscaler commitments shrink.
Arm is the toll booth on agentic AI compute, and the toll just got bigger.
